Does Rallies show Form 4 insider transactions for CBUS?

Yes. Rallies tracks CBUS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CBUS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CBUS. It does not provide personalized investment advice.

CBUS (Cibus, Inc. Class A Common Stock) Stock Analysis - Insider Trades

Cibus, Inc. Class A Common Stock (CBUS) is a publicly traded Healthcare sector company. As of May 21, 2026, CBUS trades at $1.42 with a market cap of $97.70M and a P/E ratio of -0.13. CBUS moved +8.46% today. Year to date, CBUS is -29.70%; over the trailing twelve months it is -49.73%. Its 52-week range spans $1.09 to $6.10. Analyst consensus is buy with an average price target of $14.67. Rallies surfaces CBUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CBUS stock inside the company?

Recent CBUS insider activity includes Sauer Noel sold 4, Prante Gerhard sold 1.15K, Prante Gerhard sold 1.15K, Prante Gerhard sold 1.15K, and Prante Gerhard sold 1.15K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CBUS Key Metrics

Key financial metrics for CBUS
Metric	Value
Price	$1.42
Market Cap	$97.70M
P/E Ratio	-0.13
EPS	$-10.83
Dividend Yield	0.00%
52-Week High	$6.10
52-Week Low	$1.09
Volume	0
Avg Volume	0
Revenue (TTM)	$4.26M
Net Income	$-282.71M
Gross Margin	0.00%

Recent CBUS Insider Trades

Sauer Noel sold 4 (~$5.94) on Jun 13, 2025.
Prante Gerhard sold 1.15K (~$2.21K) on Feb 25, 2025.
Prante Gerhard sold 1.15K (~$2.38K) on Feb 24, 2025.
Prante Gerhard sold 1.15K (~$2.53K) on Feb 21, 2025.
Prante Gerhard sold 1.15K (~$2.70K) on Feb 20, 2025.

Latest CBUS News

Cibus Raises $37M but Logs $21.2M Loss, Rice Launch Delayed to 2029 — May 15, 2026
Cibus Transfers Gene-Edited Rice Herbicide Tolerance Traits to Interoc for Testing and Production in South America — May 4, 2026
Cibus Prices 6.98 Million Share Offering at $2.15 to Raise $15M — Mar 26, 2026
Cibus Inc Cuts Expenses and Secures $200M Rice Partnerships Despite $31.9M Q4 Loss — Mar 18, 2026

CBUS Analyst Consensus

3 analysts cover CBUS: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.67.

Common questions about CBUS

Who is trading CBUS stock inside the company?: Recent CBUS insider activity includes Sauer Noel sold 4, Prante Gerhard sold 1.15K, Prante Gerhard sold 1.15K, Prante Gerhard sold 1.15K, and Prante Gerhard sold 1.15K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CBUS?: Yes. Rallies tracks CBUS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CBUS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CBUS. It does not provide personalized investment advice.